AMS
- Biotech – industrial & Environmental
- Supplier, engineering
AMS is a venture-backed Nuclear Medicine start-up leading the transformation of Japan’s nuclear sector. In the wake of the 2011 Fukushima nuclear accident, AMS is pioneering a new generation of nuclear medicine technologies that address systemic inefficiencies, regulatory bottlenecks, and limited access within the domestic market — through a dual focus on clinical innovation and infrastructure advancement. With two integrated business divisions — Theranostics Development (TD) and Engineering Solutions (ES) — AMS is positioned to shape the future of precision healthcare across the country.
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}